TMEM16A inhibitors as a Polycystic kidney disease (PKD) treatment option
TMEM16A inhibitors as a Polycystic kidney disease (PKD) treatment option
- TMEM16A inhibitors include approved and well-tolerated drugs such as niclosamide and benzbromarone
- Significant suppression of renal cysts
- Combinable with other strategies
